|
INDP Indaptus Therapeutics Inc 1857044 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-2,541,070.00 |
| Balance Sheet |
|
Current Assets
|
$2,180,856.00 |
|
Assets
|
$9,310,168.00 |
|
Current Liabilities
|
$932,999.00 |
|
Liabilities
|
$3,393,881.00 |
|
Equity
|
$1,247,857.00 |
|
Shares Out
|
113242324.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-7,009,993.00 |
|
Investing Cash Flow
|
$17,140,568.00 |
| Market Analysis |
Market Cap
|
$163,068,946.56 |
|
Price
|
$1.39 |
|
BVPS
|
0.01 |
|
PB
|
144.00 |
|
EPS
|
-0.23 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:29 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:25 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view INDP documents filed with the SEC.
INDP Filings
Clear
